FDA Approved: DIPROLENE — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Diprolene (betamethasone dipropionate) submitted by Organon LLC, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis
• Psoriasis

Drugs mentioned

• DIPROLENE (Betamethasone dipropionate)

Snippet

SUPPL AP for DIPROLENE (BETAMETHASONE DIPROPIONATE)